论文部分内容阅读
目的分析胺碘酮与参松养心胶囊在50例冠心病伴室性早搏患者治疗中的应用价值。方法选择2014年6月~2016年5月期间我院收治的冠心病伴室性早搏患者50例,分为两组,对照组使用胺碘酮治疗,联合组使用胺碘酮与参松养心胶囊联合治疗,对比分析两组治疗疗效。结果两组不良反应发生率比较无明显差异,P>0.05;但联合组总有效率高于对照组,P<0.05。结论胺碘酮与参松养心胶囊联合用于治疗冠心病伴室性早搏的效果显著,可推广。
Objective To analyze the value of amiodarone and shensongyangxin capsule in the treatment of 50 cases of coronary heart disease with premature ventricular contractions. Methods Fifty patients with coronary heart disease and premature ventricular contractions treated in our hospital from June 2014 to May 2016 were divided into two groups. The patients in the control group were treated with amiodarone. The amiodarone and amygdala Capsule combination therapy, comparative analysis of two groups curative effect. Results There was no significant difference in the incidence of adverse reactions between the two groups (P> 0.05). However, the total effective rate in the combination group was higher than that in the control group (P <0.05). Conclusions Amiodarone and Shensong Yangxin Capsule are effective in treating coronary heart disease with ventricular premature beats.